Article
Therapeutic targeting of oligodendrocytes in an agent-based model of multiple sclerosis
2025-06-27
Abstract excerpt
Multiple sclerosis (MS) is a neurodegenerative disease in which misdirected, persistent activity of the immune system degrades the protective myelin sheaths of nerve axons. Historically, treatment of MS has relied on disease-modifying therapies that involve immunosuppression, such as targeting of the blood-brain barrier (BBB) to restrict lymphocyte movement. New therapeutic ideas in the development pipeline are in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 601b5443-9d9c-5030-b984-c1ac289cce39
- DOI
- 10.1101/2025.06.26.661705
